Compare ResMed Inc. (RMD) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ResMed Inc. vs Zoetis Inc — how do they compare? ResMed Inc. trades at $196 (market cap $28.81B), while Zoetis Inc trades at $76.07 (market cap $31.95B). The key difference: ResMed Inc. and Zoetis Inc are close in size by market cap, and Zoetis Inc pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| RMD | ZTS | |
|---|---|---|
Market Cap | $28.81B | $31.95B |
Sector | Health | Health |
52-Week High | $293.73 | $156.76 |
52-Week Low | $182.82 | $71.91 |
Enterprise Value | $27.99B | $39.24B |
Dividend Yield | 1.21% | 2.78% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
